Andrology · 2026
Slit2/Robo Signaling Restores Diabetic Erectile Function via Neurovascular Remodeling.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fu Sen, Hu Peng, Yang Zizhong, Jin Zhenghui, Zhu Xiaoyu, Wang Tao, Liu Jihong, Cui Kai
Аннотация
BACKGROUND: Diabetes mellitus-induced erectile dysfunction (DMED) is a common and debilitating vascular-neurogenic complication of diabetes. The poor responsiveness of DMED patients to phosphodiesterase type-5 inhibitors underscores the need for therapies capable of restoring both endothelial integrity and cavernous nerve function. The Slit2/Roundabout (Robo) pathway, a conserved regulator of axon guidance and vascular remodeling, is well positioned to coordinate neurovascular repair; however, its involvement in DMED remains largely undefined.
METHODS: Single-cell RNA sequencing from embryonic genital tubercle to postnatal stages was used to map fibroblast-endothelial-neuronal signaling and identify Slit2 as a key secreted ligand. Diabetic and control mouse corpus cavernosum tissues were analyzed for endothelial and neuronal Slit2-Robo1/4 activity. In vitro, recombinant Slit2-N was applied to cells under high glucose to assess proliferation, migration, tube/sprout formation, and neurite outgrowth; Robo1/4 knockdown tested receptor dependency. In vivo, AAV-Slit2 was delivered intracavernously to diabetic mice, with erectile function assessed by sodium-nitroprusside perfusion and electrostimulation, and structural remodeling evaluated by endothelial, neural, and fibrosis markers.
RESULTS: Single-cell profiling identified Slit2 as a fibroblast-derived developmental cue for corpus cavernosum morphogenesis. Diabetic mice exhibited markedly reduced endothelial and neuronal Slit2-Robo signaling. Slit2-N restored angiogenic and neuroregenerative functions in vitro under high glucose, enhancing endothelial activity and neurite growth; all effects were lost after Robo1/4 silencing. In vivo, AAV-Slit2 re-established local Slit2 signaling, improved penile perfusion and erectile responses, enhanced endothelial proliferation and nerve regeneration, and reduced fibrosis, indicating substantial neurovascular recovery.
CONCLUSIONS: Slit2/Robo signaling is a key regulatory axis disrupted in DMED. Local restoration of Slit2 via AAV delivery drives synchronized neurovascular regeneration and effectively rescues erectile function in diabetic mice. These findings establish Slit2 as a promising therapeutic target for reversing the underlying pathophysiology of DMED rather than merely providing symptomatic relief.
METHODS: Single-cell RNA sequencing from embryonic genital tubercle to postnatal stages was used to map fibroblast-endothelial-neuronal signaling and identify Slit2 as a key secreted ligand. Diabetic and control mouse corpus cavernosum tissues were analyzed for endothelial and neuronal Slit2-Robo1/4 activity. In vitro, recombinant Slit2-N was applied to cells under high glucose to assess proliferation, migration, tube/sprout formation, and neurite outgrowth; Robo1/4 knockdown tested receptor dependency. In vivo, AAV-Slit2 was delivered intracavernously to diabetic mice, with erectile function assessed by sodium-nitroprusside perfusion and electrostimulation, and structural remodeling evaluated by endothelial, neural, and fibrosis markers.
RESULTS: Single-cell profiling identified Slit2 as a fibroblast-derived developmental cue for corpus cavernosum morphogenesis. Diabetic mice exhibited markedly reduced endothelial and neuronal Slit2-Robo signaling. Slit2-N restored angiogenic and neuroregenerative functions in vitro under high glucose, enhancing endothelial activity and neurite growth; all effects were lost after Robo1/4 silencing. In vivo, AAV-Slit2 re-established local Slit2 signaling, improved penile perfusion and erectile responses, enhanced endothelial proliferation and nerve regeneration, and reduced fibrosis, indicating substantial neurovascular recovery.
CONCLUSIONS: Slit2/Robo signaling is a key regulatory axis disrupted in DMED. Local restoration of Slit2 via AAV delivery drives synchronized neurovascular regeneration and effectively rescues erectile function in diabetic mice. These findings establish Slit2 as a promising therapeutic target for reversing the underlying pathophysiology of DMED rather than merely providing symptomatic relief.